Q
QGEN
Qiagen
40.89
-0.12-0.29%After Hours: 40.89 0.00 0.00%16:04 04/10 EDT
OPEN/PREV CLOSE41.17/41.01
TODAY RANGE40.64-41.52
VOL1.16M
MARKET CAP8.43B
52 WEEK RANGE38.44-57.82
AVG VOL (3M)2.41M
% TURNOVER0.56%
TURNOVER--
P/E (TTM)21.03
% RANGE2.14%
EPS(TTM)1.944
P/E(FORWARD)19.47
P/B2.344
BVPS17.45
DIVIDEND0.2500
P/S4.237
BETA--
DIV YIELD0.61%
FREE FLOAT MKT CAP8.23B
SHARES OUTSTANDING206.07M
NEXT EARNINGS05/05-05/11
FREE FLOAT201.30M
LOT SIZE1
EX-DATE07/02/2025
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
BlackRock Discloses Double-Digit Stake in Qiagen
TipRanks·2d ago
BlackRock Raises Substantial Stake in Qiagen to Over 10%
Reuters·2d ago
BlackRock lifts Qiagen voting rights stake to 11.8%
Simply Wall St·4d ago
How Investors May Respond To Qiagen (QGEN) Upgrade After Reaffirmed 5% Outlook And New Product Plans
TipRanks·04/02 21:08
Bank of America Discloses 3.01% Voting Stake in Qiagen
TipRanks·04/01 11:41
Bruker appoints Bernard to its Board of Directors
Reuters·04/01 11:02
Bruker appoints QIAGEN CEO Thierry Bernard to board of directors
Reuters·03/31 21:58
Qiagen publishes UK gender pay gap report showing 11.7% mean hourly pay gap
Simply Wall St·03/30 04:20
The Bull Case For Qiagen (QGEN) Could Change Following New QuantiFERON-TB Gold Plus Evidence - Learn Why
Simply Wall St·03/28 11:07
Qiagen (QGEN) Valuation Check As New QuantiFERON TB Data Reinforces Leadership In Tuberculosis Detection
Reuters·03/27 21:06
Vanguard Group voting rights in Qiagen rise to 3.15% in Qiagen
Simply Wall St·03/20 00:16
Qiagen’s TB And GI Testing Moves Draw Investor Valuation Interest
TipRanks·03/19 20:17
Qiagen announces newly published data supporting efficacy of QuantiFERON